Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing

Area of Science:

• Oncology
• Molecular Biology
• Gene Therapy

Background:

• MDA-7/interleukin-24 is a potent tumor suppressor.
• Targeting specific subcellular compartments can enhance gene therapy efficacy.
• Endoplasmic reticulum (ER) stress is implicated in apoptosis pathways.

Purpose of the Study:

• To develop and evaluate adenoviral vectors expressing MDA-7/IL-24 targeted to various subcellular compartments.
• To investigate the efficacy of ER-targeted Ad-ER-mda7 in inhibiting cancer cell growth and proliferation.
• To elucidate the molecular mechanisms underlying Ad-mda7 and Ad-ER-mda7-induced apoptosis.

Main Methods:

• Construction of adenoviral vectors targeting MDA-7/IL-24 to the ER, mitochondria, nucleus, and cytosol.
• In vitro evaluation of vector efficacy against lung and esophageal cancer cell lines (A549, H1299, Seg1, Bic1).
• Analysis of apoptosis pathways, including ER stress markers (phosphorylated JNK, c-Jun, RNA-dependent protein kinase) and caspase-4 activation.

Main Results:

• Ad-ER-mda7 selectively inhibited growth and proliferation of lung and esophageal cancer cells.
• Both Ad-mda7 and Ad-ER-mda7 activated a novel ER stress-induced apoptosis pathway.
• Caspase-4 activation mediated Ad-mda7 and Ad-ER-mda7-induced cell death.
• Growth inhibition correlated with activation of ER molecular markers RNA-dependent protein kinase and JNK in vitro and in vivo.

Conclusions:

• Adenoviral vectors targeting MDA-7/IL-24 to the ER (Ad-ER-mda7) are effective in inducing cancer cell apoptosis.
• ER stress induction via Ad-ER-mda7 represents a promising strategy for cancer gene therapy.
• The pathway involves activation of phosphorylated JNK, c-Jun, RNA-dependent protein kinase, and caspase-4.